from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2805/-

LFCtreatmentdescriptionclass of inhibitor

0.951

Amikacinug/mL Amikacintranslation

0.758

Cap5-10ug/mL Capreomycintranslation

2.152

Rox10-50 ug/mL Roxithromycintranslation

0.178

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.361

Rif0.2-5ug/mL Rifampicintranscription

0.336

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.893

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.971

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.004

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.662

Clofazimine10-13 ug/mL Clofaziminerespiration

1.033

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.502

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.130

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.045

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.207

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.020

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.178

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.288

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.308

KCN5-20 ug/mL Potassium cyaniderespiration

0.945

NaN30.2-2 mM Sodium aziderespiration

0.517

Nigericin50 uM Nigericinrespiration

0.252

TRC10-150 ug/mL Triclosanrespiration

0.716

TRZ10-25 ug/mL Thioridazinerespiration

-1.263

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.027

menadione6-10 ug/mL Menadionerespiration

-0.062

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.619

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.015

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.769

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.393

NRP_1Non-replicating persistence stage 1dosRassociated

-0.336

Amp0.2mg/mL AmpicillincellWall

-0.030

Cephalexin20-100 ug/mL CephalexincellWall

0.700

Cerulenin0.32-5 ug/mL CerulenincellWall

0.392

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.473

EMB10-20 ug/mL EthambutolcellWall

0.102

Eta12-40 ug/mL EthionamidecellWall

0.206

INH0.2-0.4 ug/mL IsoniazidcellWall

0.341

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.575

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.152

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.665

BZA0.12 mg/mL BenzamidearomaticAmides

0.287

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.099

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.891

H2O24 mM hydrogen peroxideDNAdamaging

0.089

Levo10 ug/mL LevofloxacinDNAdamaging

0.439

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.320

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.279

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.261

UVUV-irradiationDNAdamaging

-1.426

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.291

Antimycin12.5-50 ug/mL Antimycin A?

-0.088

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.046

PA_110-50 ug/mL Antitubercular compound PA-1?

0.179

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.137

PA8240.2-2 ug/mL PA-824?

-1.167

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.213

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.456

Verapamil50 uM Verapamil?

-0.369

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.760

methoxatin10-20 ug/mL Methoxatin?